O
Oragenics, Inc. (OGEN)
ASE – Real vaqt narxi. Valyuta: USD
0.59
+0.03 (5.45%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.58
-0.01 (-1.36%)
Bozor oldidan: May 13, 2026, 5:13 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
0.59
+0.03 (5.45%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.58
-0.01 (-1.36%)
Bozor oldidan: May 13, 2026, 5:13 AM EDT
Oragenics, Inc., rivojlanish bosqichidagi kompaniya, Amerika Qo'shma Shtatlarida nevrologik kasalliklar va yuqumli kasalliklar uchun burun orqali yetkaziladigan farmatsevtika terapiyalarini tadqiq qilish va ishlab chiqish bilan shug'ullanadi. Uning asosiy mahsuloti ONP-002 hisoblanadi, bu to'liq sintetik, tabiiy bo'lmagan neyrosteroiddir, u lipofil va qon-miya to'sig'ini kesib o'tishi mumkin, shishishni, oksidlovchi stressni va yallig'lanishni kamaytirish, shu bilan birga gen amplifikatsiyasi orqali qon oqimini tiklash va yengil travmatik miya shikastlanishini davolash uchun. Kompaniya avval Oragen, Inc. nomi bilan tanilgan. Oragenics, Inc. 1996 yilda tashkil etilgan va shtab-kvartirasi Florida shtatidagi Lakewood Ranch shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. James P. Kelly M.A., M.D. | Chief Medical Officer |
| Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D. | Chief Clinical Officer |
| Mr. Charles L. Pope CPA | Executive Chairman |
| Ms. Janet Huffman | CEO, President, CFO, Secretary & Treasurer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 10-Q | form10-q.htm |
| 2026-05-07 | 8-K | form8-k.htm |
| 2026-04-13 | 8-K | form8-k.htm |
| 2026-03-31 | 8-K | form8-k.htm |
| 2026-03-19 | S-3/A | forms-3a.htm |
| 2026-03-16 | 10-K | form10-k.htm |
| 2026-03-11 | 8-K | form8-k.htm |
| 2026-01-22 | S-3 | forms-3.htm |
| 2026-01-20 | 8-K | form8-k.htm |
| 2025-12-15 | 8-K | form8-k.htm |